Related Experiment Video
Updated: Apr 16, 2026

Neutrophil Lifespan Extension with CLON-G and an In Vitro Spontaneous Death Assay
Published on: May 12, 2023
[Pulmonary infection in neutropenia]
M Haap1, B Neumayer2, H-G Kopp1
1Abteilung für Endokrinologie, Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Medizinische Klinik und Poliklinik, Universitätsklinikum Tübingen.
Patients with relapsed hairy cell leukemia and neutropenia face high risks of fungal infections. Early prophylactic antifungal therapy is crucial, and vemurafenib shows promise for refractory cases, though complications can be fatal.
Area of Science:
- Hematology
- Mycology
- Oncology
Background:
- Hairy cell leukemia (HCL) is a rare B-cell malignancy.
- Treatment-refractory HCL poses significant management challenges.
- Patients with prolonged neutropenia are susceptible to opportunistic infections.
Observation:
- A 42-year-old patient with relapsed HCL developed shortness of breath and chest pain.
- Imaging revealed bilateral infiltrates and pleural effusions, suspicious for fungal infection.
- The patient experienced severe cytopenias, respiratory failure, and died despite aggressive treatment.
Findings:
- Diagnosis confirmed relapsed HCL with BRAF mutation and >80% bone marrow infiltration.
- Autopsy showed disseminated fungal hyphae in lungs and spleen, with hepato-splenomegaly and pancytopenia.
- Aspergillus antigen was detected and cleared with antifungal therapy, but septic complications led to death.
Implications:
- Refractory HCL with neutropenia necessitates early consideration of prophylactic antifungal therapy.
- Vemurafenib represents a potential therapeutic option for treatment-refractory HCL.
- This case highlights the critical risk of systemic fungal infections and the challenges in managing HCL complications.
More Related Videos
08:33A Method for Generating Pulmonary Neutrophilia Using Aerosolized Lipopolysaccharide
Published on: December 15, 2014
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology
Pneumonia III: Complications and Assessment
Atypical Pneumonia
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...